Episona adds D2C model for male fertility test using epigenetics
Seed is a next-generation sequencing test that identifies signs of DNA methylation in sperm as the result of aging, smoking, pollution and other factors.
Epigenetics startup Episona launches male fertility test
The global market for fertility medicine is now $30-40 billion per year, but many continue to view it as a women's health problem. Episona hopes to change that, with its epigenetics-based male fertility test.
The Power of Real World Data to Study Women’s Health at Scale
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!